$SPRO Spero Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Spero Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Spero Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Spero Therapeutics, Inc. for free.
CIK Number: 0001701108
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SPRO
Company Address: 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE 02139
Phone number: 857-242-1600
Former name: Spero Therapeutics, LLC, date of change: 2017-03-16
Spero Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 10 2021 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 21.74 | 3,000 | 65,215 | 3,829,209 | 3.8 M to 3.8 M (-0.08 %) |
Feb 04 2021 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 18.99 | 34,144 | 648,255 | 3,832,209 | 3.9 M to 3.8 M (-0.88 %) |
Feb 04 2021 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 18.98 | 29,354 | 557,101 | 3,866,353 | 3.9 M to 3.9 M (-0.75 %) |
Feb 04 2021 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 18.99 | 22,841 | 433,771 | 3,895,707 | 3.9 M to 3.9 M (-0.58 %) |
Feb 04 2021 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 19.24 | 13,661 | 262,861 | 3,918,548 | 3.9 M to 3.9 M (-0.35 %) |
Feb 03 2021 | SPRO | Spero Therapeutics ... | Keutzer Timothy | Chief Development O ... | Option Exercise | A | 19.18 | 57,432 | 1,101,546 | 57,432 | |
Feb 03 2021 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Option Exercise | A | 19.18 | 57,432 | 1,101,546 | 57,432 | |
Feb 03 2021 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | A | 19.18 | 179,319 | 3,439,338 | 179,319 | |
Feb 03 2021 | SPRO | Spero Therapeutics ... | Melnick David A. | Chief Medical Offic ... | Option Exercise | A | 19.18 | 57,432 | 1,101,546 | 57,432 | |
Jan 06 2021 | SPRO | Spero Therapeutics ... | Smith Cynthia | Director | Option Exercise | A | 17.93 | 2,629 | 47,138 | 2,629 | |
Jan 06 2021 | SPRO | Spero Therapeutics ... | THOMAS FRANK E | Director | Option Exercise | A | 17.93 | 1,314 | 23,560 | 1,314 | |
Jan 06 2021 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 17.93 | 2,629 | 47,138 | 2,629 | |
Dec 18 2020 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 18.81 | 250,000 | 4,703,225 | 3,932,209 | 4.2 M to 3.9 M (-5.98 %) |
Dec 18 2020 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 18.62 | 14,933 | 278,035 | 4,182,209 | 4.2 M to 4.2 M (-0.36 %) |
Nov 10 2020 | SPRO | Spero Therapeutics ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 13.77 | 125,900 | 1,734,071 | 4,197,142 | 4.3 M to 4.2 M (-2.91 %) |